Why the study?
Does atropine affect cardiac vagal efferent activity and heart rate in anesthetized dogs?
Does atropine affect cardiac vagal efferent activity and heart rate in anesthetized dogs?
Atropine exerts a powerful central stimulating effect on cardiac vagal efferent activity while simultaneously blocking vagal heart rate effects at the periphery in dogs.
Answers are grounded in this paper and cite their sources.
Reveals dual central-peripheral atropine actions in dogs; leaves open translation to human vagal modulation.
Cardiac vagal efferent (CVE) activity was recorded from fine strands of the cervical vagus of chloralose-urethane-anesthetized dogs weighing an average of 14.6 kg. In spontaneously breathing animals atropine sulfate in doses of 0.003-1.5 mg significantly increased CVE activity even when the activity was corrected for changes in blood pressure. A 50% average increase (P less than 0.001) in mean activity was observed at a dose of 0.15 mg. The increase was not abolished by vagotomy as long as the animals were allowed to breathe spontaneously. The peripheral effect of atropine was characterized by the relationship between CVE activity and measured heart period changes. A 50% peripheral blockade was achieved at a dose of 0.06 mg; a dose of 1.0 mg produced essentially complete (greater than 90%) blockade. The results quantitatively demonstrate that atropine exerts a powerful central stimulating effect on CVE activity while simultaneously blocking vagal heart rate effects at the periphery.
No takes yet. Share an insight, caveat, or question.
Katona et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: